Sinovac Biotech Ltd NASDAQ NMS - GLOBAL MARKET:SVA
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
New Positions(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Aprio Wealth Management, LLC | 439 | +439 | $284.0K | +$284.0K | — |
| IFP Advisors, Inc | 400 | +400 | $0 | $0 | — |
Added To(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| UBS Group AG | 9,222 | +7,000 | $59.7K | +$45.3K | 315.0% |
| JONES FINANCIAL COMPANIES LLLP | 338 | +300 | $0 | $0 | 789.5% |
| ASSETMARK, INC | 26 | +2 | $0 | $0 | 8.3% |
Reduced(23)
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 2,718,735 | $184.5M | 0 | 0.0% |
| Vivo Capital, LLC | 5,903,000 | $38.2M | 0 | 0.0% |
| Aprio Wealth Management, LLC | 439 | $284.0K | +439 | — |
| WELLS FARGO & COMPANY/MN | 16,876 | $109.2K | 0 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,430 | $106.3K | 0 | 0.0% |
| UBS Group AG | 9,222 | $59.7K | +7,000 | 315.0% |
| MORGAN STANLEY | 9,144 | $59.2K | 0 | 0.0% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2.0K | 0 | 0.0% |
| Horizon Investments, LLC | 52 | $336 | 0 | 0.0% |
| FINANCIAL CONSULATE, INC | 23 | $0 | 0 | 0.0% |
| ASSETMARK, INC | 26 | $0 | +2 | 8.3% |
| Atlantic Edge Private Wealth Management, LLC | 1,000 | $0 | 0 | 0.0% |
| NAVELLIER & ASSOCIATES INC | 13,018 | $0 | -550 | -4.0% |
| IFP Advisors, Inc | 400 | $0 | +400 | — |
| Clearstead Advisors, LLC | 500 | $0 | 0 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,717 | $0 | 0 | 0.0% |
| Spark Investment Management LLC | 29,100 | $0 | 0 | 0.0% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $0 | 0 | 0.0% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 68,732 | $0 | 0 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 1,312,520 | $0 | 0 | 0.0% |
New & Closed Positions this quarter
No managers exited their positions this quarter.
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for SVA against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.